The GMED stock price forecast reflects increased optimism due to MedTech innovation pipelines. This is fueled by year-over-year revenue growth of over 12%, with traders eyeing breakout potential above $64 as momentum indicators strengthen in weekly charts. Numerous megatrends in the healthcare industry are to blame for this considerable expansion. One of the main elements influencing the sector is the aging of the global population. This is particularly true in wealthy nations like the US, where, as of 2023, 17% of the population is 65 years of age or older. The demand for medical equipment is ultimately being driven by the rise in the prevalence of chronic diseases. To track analyst ratings and price targets for $GMED, check out Quiver Quantitative's $GMED forecast page. Fibonacci retracement levels place GMED’s key support at $60.30 and next resistance at $66.